BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marques MRC, Choo Q, Ashtikar M, Rocha TC, Bremer-Hoffmann S, Wacker MG. Nanomedicines - Tiny particles and big challenges. Adv Drug Deliv Rev 2019;151-152:23-43. [PMID: 31226397 DOI: 10.1016/j.addr.2019.06.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Zarinwall A, Maurer V, Pierick J, Oldhues VM, Porsiel JC, Finke JH, Garnweitner G. Amorphization and modified release of ibuprofen by post-synthetic and solvent-free loading into tailored silica aerogels. Drug Deliv 2022;29:2086-99. [PMID: 35838584 DOI: 10.1080/10717544.2022.2092237] [Reference Citation Analysis]
2 Wang X, Fan Y, Yan J, Yang M. Engineering polyphenol-based polymeric nanoparticles for drug delivery and bioimaging. Chemical Engineering Journal 2022;439:135661. [DOI: 10.1016/j.cej.2022.135661] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Manocha S, Dhiman S, Grewal AS, Guarve K. Nanotechnology: An approach to overcome bioavailability challenges of nutraceuticals. Journal of Drug Delivery Science and Technology 2022;72:103418. [DOI: 10.1016/j.jddst.2022.103418] [Reference Citation Analysis]
4 Bokhary KA, Maqsood F, Amina M, Aldarwesh A, Mofty HK, Al-Yousef HM. Grapefruit Extract-Mediated Fabrication of Photosensitive Aluminum Oxide Nanoparticle and Their Antioxidant and Anti-Inflammatory Potential. Nanomaterials (Basel) 2022;12:1885. [PMID: 35683744 DOI: 10.3390/nano12111885] [Reference Citation Analysis]
5 Villa Nova M, Gan K, Wacker MG. Biopredictive tools for the development of injectable drug products. Expert Opin Drug Deliv 2022. [PMID: 35603724 DOI: 10.1080/17425247.2022.2081682] [Reference Citation Analysis]
6 Tutty MA, Movia D, Prina-Mello A. Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials. Drug Deliv Transl Res 2022. [PMID: 35507131 DOI: 10.1007/s13346-022-01147-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu Z, Zhou X, Li Q, Shen Y, Zhou T, Liu X. Macrophage-evading and tumor-specific apoptosis inducing nanoparticles for targeted cancer therapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Popov AB, Melle F, Linnane E, González-López C, Ahmed I, Parshad B, Franck CO, Rahmoune H, Richards FM, Muñoz-Espín D, Jodrell DI, Fairen-Jimenez D, Fruk L. Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer. Nanoscale 2022. [PMID: 35438701 DOI: 10.1039/d2nr00864e] [Reference Citation Analysis]
9 Bekmukhametova A, Uddin MMN, Houang J, Malladi C, George L, Wuhrer R, Barman SK, Wu MJ, Mawad D, Lauto A. Fabrication and characterization of chitosan nanoparticles using the coffee-ring effect for photodynamic therapy. Lasers Surg Med 2022. [PMID: 35195285 DOI: 10.1002/lsm.23530] [Reference Citation Analysis]
10 Villa Nova M, Lin TP, Shanehsazzadeh S, Jain K, Ng SCY, Wacker R, Chichakly K, Wacker MG. Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence. Front Digit Health 2022;4:799341. [DOI: 10.3389/fdgth.2022.799341] [Reference Citation Analysis]
11 Barton AE, Borchard G, Wacker MG, Pastorin G, Saleem IY, Chaudary S, Elbayoumi T, Zhao Z, Flühmann B. Need for Expansion of Pharmacy Education Globally for the Growing Field of Nanomedicine. Pharmacy 2022;10:17. [DOI: 10.3390/pharmacy10010017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ramos TI, Villacis-aguirre CA, López-aguilar KV, Santiago Padilla L, Altamirano C, Toledo JR, Santiago Vispo N. The Hitchhiker’s Guide to Human Therapeutic Nanoparticle Development. Pharmaceutics 2022;14:247. [DOI: 10.3390/pharmaceutics14020247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Mast MP, Modh H, Champanhac C, Wang JW, Storm G, Krämer J, Mailänder V, Pastorin G, Wacker MG. Nanomedicine at the crossroads - A quick guide for IVIVC. Adv Drug Deliv Rev 2021;179:113829. [PMID: 34174332 DOI: 10.1016/j.addr.2021.113829] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
14 Mast MP, Modh H, Knoll J, Fecioru E, Wacker MG. An Update to Dialysis-Based Drug Release Testing-Data Analysis and Validation Using the Pharma Test Dispersion Releaser. Pharmaceutics 2021;13:2007. [PMID: 34959289 DOI: 10.3390/pharmaceutics13122007] [Reference Citation Analysis]
15 Talebian S, Rodrigues T, das Neves J, Sarmento B, Langer R, Conde J. Facts and Figures on Materials Science and Nanotechnology Progress and Investment. ACS Nano 2021;15:15940-52. [PMID: 34320802 DOI: 10.1021/acsnano.1c03992] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
16 Xu Q, Xu Y, Xue J, Zhu F, Zhong Z, Liu R. An innovative alcohol-solution combustion-calcination process for the fabrication of NiFe 2 O 4 nanorods and their adsorption characteristics of methyl blue in aqueous solution. Mater Res Express 2021;8:095003. [DOI: 10.1088/2053-1591/ac1ecd] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Hu X, Jazani AM, Oh JK. Recent advances in development of imine-based acid-degradable polymeric nanoassemblies for intracellular drug delivery. Polymer 2021;230:124024. [DOI: 10.1016/j.polymer.2021.124024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
18 Veloso PM, Machado R, Nobre C. Mesalazine and inflammatory bowel disease - From well-established therapies to progress beyond the state of the art. Eur J Pharm Biopharm 2021;167:89-103. [PMID: 34329709 DOI: 10.1016/j.ejpb.2021.07.014] [Reference Citation Analysis]
19 Dau VT, Bui TT, Tran CD, Nguyen TV, Nguyen TK, Dinh T, Phan HP, Wibowo D, Rehm BHA, Ta HT, Nguyen NT, Dao DV. In-air particle generation by on-chip electrohydrodynamics. Lab Chip 2021;21:1779-87. [PMID: 33730135 DOI: 10.1039/d0lc01247e] [Reference Citation Analysis]
20 Halamoda-Kenzaoui B, Rolland E, Piovesan J, Puertas Gallardo A, Bremer-Hoffmann S. Toxic effects of nanomaterials for health applications: How automation can support a systematic review of the literature? J Appl Toxicol 2021. [PMID: 34050552 DOI: 10.1002/jat.4204] [Reference Citation Analysis]
21 Tavares Luiz M, Santos Rosa Viegas J, Palma Abriata J, Viegas F, Testa Moura de Carvalho Vicentini F, Lopes Badra Bentley MV, Chorilli M, Maldonado Marchetti J, Tapia-Blácido DR. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. Eur J Pharm Biopharm 2021;165:127-48. [PMID: 33992754 DOI: 10.1016/j.ejpb.2021.05.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
22 Rae JM, Jachimska B. Analysis of dendrimer-protein interactions and their implications on potential applications of dendrimers in nanomedicine. Nanoscale 2021;13:2703-13. [PMID: 33496716 DOI: 10.1039/d0nr07607d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
23 Franco P, De Marco I. Nanoparticles and Nanocrystals by Supercritical CO2-Assisted Techniques for Pharmaceutical Applications: A Review. Applied Sciences 2021;11:1476. [DOI: 10.3390/app11041476] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
24 Guo S, Liang Y, Liu L, Yin M, Wang A, Sun K, Li Y, Shi Y. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics. J Nanobiotechnology 2021;19:32. [PMID: 33499885 DOI: 10.1186/s12951-021-00770-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Wang W, Zhou C. A Journey of Nanomotors for Targeted Cancer Therapy: Principles, Challenges, and a Critical Review of the State-of-the-Art. Adv Healthc Mater 2021;10:e2001236. [PMID: 33111501 DOI: 10.1002/adhm.202001236] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 21.0] [Reference Citation Analysis]
26 Yeung AWK, Souto EB, Durazzo A, Lucarini M, Novellino E, Tewari D, Wang D, Atanasov AG, Santini A. Big impact of nanoparticles: analysis of the most cited nanopharmaceuticals and nanonutraceuticals research. Current Research in Biotechnology 2020;2:53-63. [DOI: 10.1016/j.crbiot.2020.04.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
27 Joshi AS, Singh P, Mijakovic I. Interactions of Gold and Silver Nanoparticles with Bacterial Biofilms: Molecular Interactions behind Inhibition and Resistance. Int J Mol Sci 2020;21:E7658. [PMID: 33081366 DOI: 10.3390/ijms21207658] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
28 Huang C, Neupane YR, Lim XC, Shekhani R, Czarny B, Wacker MG, Pastorin G, Wang JW. Extracellular vesicles in cardiovascular disease. Adv Clin Chem 2021;103:47-95. [PMID: 34229852 DOI: 10.1016/bs.acc.2020.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
29 Jung F, Thurn M, Krollik K, Gao GF, Hering I, Eilebrecht E, Emara Y, Weiler M, Günday-Türeli N, Türeli E, Parnham MJ, Wacker MG. Predicting the environmental emissions arising from conventional and nanotechnology-related pharmaceutical drug products. Environ Res 2021;192:110219. [PMID: 32980299 DOI: 10.1016/j.envres.2020.110219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Kad A, Pundir A, Arya SK, Bhardwaj N, Khatri M. An Elucidative Review to Analytically Sieve the Viability of Nanomedicine Market. J Pharm Innov 2020;:1-17. [PMID: 32983280 DOI: 10.1007/s12247-020-09495-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kischkel B, Rossi SA, Santos SR, Nosanchuk JD, Travassos LR, Taborda CP. Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections. Front Cell Infect Microbiol 2020;10:463. [PMID: 33014889 DOI: 10.3389/fcimb.2020.00463] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
32 Panzade PS, Shendarkar GR. Pharmaceutical cocrystal: a game changing approach for the administration of old drugs in new crystalline form. Drug Dev Ind Pharm 2020;46:1559-68. [PMID: 32799687 DOI: 10.1080/03639045.2020.1810270] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Mejlsøe S, Kakkar A. Telodendrimers: Promising Architectural Polymers for Drug Delivery. Molecules 2020;25:3995. [DOI: 10.3390/molecules25173995] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
34 Germain M, Caputo F, Metcalfe S, Tosi G, Spring K, Åslund AKO, Pottier A, Schiffelers R, Ceccaldi A, Schmid R. Delivering the power of nanomedicine to patients today. J Control Release 2020;326:164-71. [PMID: 32681950 DOI: 10.1016/j.jconrel.2020.07.007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 29.0] [Reference Citation Analysis]
35 Roces CB, Port EC, Daskalakis NN, Watts JA, Aylott JW, Halbert GW, Perrie Y. Rapid scale-up and production of active-loaded PEGylated liposomes. Int J Pharm 2020;586:119566. [PMID: 32622812 DOI: 10.1016/j.ijpharm.2020.119566] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
36 Guo H, Xia Y, Feng K, Qu X, Zhang C, Wan F. Surface Engineering of Metal-Organic Framework as pH-/NIR-Responsive Nanocarrier for Imaging-Guided Chemo-Photothermal Therapy. Int J Nanomedicine 2020;15:3235-50. [PMID: 32440121 DOI: 10.2147/IJN.S239910] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
37 Yin Y, Deng H, Wu K, He B, Dai W, Zhang H, Fu J, Le Y, Wang X, Zhang Q. A multiaspect study on transcytosis mechanism of sorafenib nanogranules engineered by high-gravity antisolvent precipitation. J Control Release 2020;323:600-12. [PMID: 32278828 DOI: 10.1016/j.jconrel.2020.04.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
38 Jablonka L, Ashtikar M, Gao GF, Thurn M, Modh H, Wang J, Preuß A, Scheglmann D, Albrecht V, Röder B, Wacker MG. Predicting human pharmacokinetics of liposomal temoporfin using a hybrid in silico model. European Journal of Pharmaceutics and Biopharmaceutics 2020;149:121-34. [DOI: 10.1016/j.ejpb.2020.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
39 Demetzos C, Kavatzikidou P, Pippa N, Stratakis E. Nanomedicines and Nanosimilars: Looking for a New and Dynamic Regulatory "Astrolabe" Inspired System. AAPS PharmSciTech 2020;21:65. [PMID: 31933006 DOI: 10.1208/s12249-019-1573-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
40 Qin M, Zhang J, Li M, Yang D, Liu D, Song S, Fu J, Zhang H, Dai W, Wang X, Wang Y, He B, Zhang Q. Proteomic analysis of intracellular protein corona of nanoparticles elucidates nano-trafficking network and nano-bio interactions. Theranostics 2020;10:1213-29. [PMID: 31938061 DOI: 10.7150/thno.38900] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
41 Wacker MG. Frontiers in pharmaceutical nanotechnology. Beilstein J Nanotechnol 2019;10:2538-40. [PMID: 31921532 DOI: 10.3762/bjnano.10.244] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Vogel V. Nanosensors and particles: a technology frontier with pitfalls. J Nanobiotechnology 2019;17:111. [PMID: 31660986 DOI: 10.1186/s12951-019-0542-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
43 Wallenwein CM, Nova MV, Janas C, Jablonka L, Gao GF, Thurn M, Albrecht V, Wiehe A, Wacker MG. A dialysis-based in vitro drug release assay to study dynamics of the drug-protein transfer of temoporfin liposomes. Eur J Pharm Biopharm 2019;143:44-50. [PMID: 31421208 DOI: 10.1016/j.ejpb.2019.08.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]